학술논문
Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week
Document Type
Article
Author
Source
In: Revista Espanola de Enfermedades Digestivas . (Revista Espanola de Enfermedades Digestivas, 2022, 114(12):708-712)
Subject
Language
English
ISSN
11300108